Home Biosimilar Antibodies Others Others Anti-KAAG1 (ADCT-901-MMAE)
For research use only. Not for use in humans.

Anti-KAAG1 (ADCT-901-MMAE)

Synonyms: ADCT-901

Anti-KAAG1 (ADCT-901-MMAE) is an ADC composed of a humanized monoclonal antibody (3A4) targeting human KAAG1. It is used for the treatment of advanced solid tumors including platinum resistant ovarian cancer and triple negative breast cancer. MW :145.28 KD.

Anti-KAAG1 (ADCT-901-MMAE)

CAS No.

Quality Control

Batch: D406201 Purity: 99% Protein concentration: 5.629mg/ml Endotoxin Level: ＜1EU/mg
99

Mechanism of Action

Description
Anti-KAAG1 (ADCT-901-MMAE) is an ADC composed of a humanized monoclonal antibody (3A4) targeting human KAAG1. It is used for the treatment of advanced solid tumors including platinum resistant ovarian cancer and triple negative breast cancer. MW :145.28 KD.
References

Product Details

Molecular Weight 145.28
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.